Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Arena Pharmaceuticals Begins Receptor Drug Discovery Collaboration With Fujisawa
Arena Pharmaceuticals Begins Receptor Drug Discovery Collaboration With Fujisawa SAN DIEGO, Jan. 31 /PRNewswire/ -- Arena Pharmaceuticals, Inc. ("Arena"), a privately held biopharmaceutical company, today announced that Arena and Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan ("Fujisawa") have
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Awarded Phase I SBIR Grant To Develop Novel, Atypical Antipsychotics
Target Is Constitutively Activated Form of Human Serotonin Receptor
View HTML
Toggle Summary Neurocrine Biosciences and Arena Pharmaceuticals Announce Receptor Collaboration
Neurocrine Biosciences and Arena Pharmaceuticals Announce Receptor Collaboration SAN DIEGO, Sept. 15 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Arena Pharmaceuticals, Inc. ("Arena"), a privately held biopharmaceutical company, today announced a collaboration involving the
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Successful Completion of Phase I Clinical Study of Novel
Potential New Treatment for Alzheimer's Disease
View HTML
Toggle Summary Arena Pharmaceuticals, Inc. Announces Successful Completion of $17 Million Private Offering
Arena Pharmaceuticals, Inc. Announces Successful Completion of $17 Million Private Offering SAN DIEGO, Feb. 22 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Arena ™ ), a privately-held biotechnology company, has announced the successful completion of a private offering through the sale of its
View HTML